Comparison of Allegra vs Sapien Transcatheter Aortic Valves in Valve-In-Valve Indication

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 104 participants.

Also called NCT06049654

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 104 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06049654
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Italy, Spain, United Kingdom (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT06049654. Randomized; no masking; primary purpose treatment. Start 2024-02-01 (actual); primary completion 2027-11-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Comparison of Allegra vs Sapien Transcatheter Aortic Valves in Valve-In-Valve Indication
Condition
Aortic Valve Stenosis
Condition
Structural Valve Deterioration
Intervention (Device)
NVT ALLEGRA TAVI System TF
Intervention (Device)
EDWARDS SAPIEN 3 or SAPIEN ULTRA SYSTEM
Lead sponsor
Fundación EPIC (class: other)

Record details

Record id
cardio:ct-nct06049654
Content hash
e90aa390ba7c77a418715255ca6de4831d5944af8dd8856212453bb32efd7835